🇺🇸 FDA
Patent

US 8785633

Guanidine-containing compounds useful as muscarinic receptor antagonists

granted A61PA61P1/04A61P1/12

Quick answer

US patent 8785633 (Guanidine-containing compounds useful as muscarinic receptor antagonists) held by Theravance Biopharma R&D IP, LLC expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P1/04, A61P1/12, A61P11/00, A61P11/02